Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on the Future of Triple Negative Breast Cancer Treatment
Joyce A. O'Shaughnessy, MD, Breast Cancer Research, Baylor Sammons Cancer Center in Dallas, TX, discusses the future of triple-negative breast cancer (TNBC) treatments.
O'Shaughnessy believes that TNBC is the biggest challenge currently facing breast cancer treatment. There is currently a large amount of testable hypotheses that may result in a major break-through. These hypotheses will further be strengthened by the results of the The Cancer Genome Atlas (TCGA) project for breast cancer.
The TCGA results should be submitted by the end of this year. A full sequence analysis of breast cancer will not only illuminate TNBC but also will shed light on potential subtypes of TNBC.